美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
LEXAPRO	021323	001	NDA	ESCITALOPRAM OXALATE	TABLET;ORAL	EQ 5MG BASE	Yes	No	2002/08/14	2002/08/14	ABBVIE	Prescription
LEXAPRO	021323	002	NDA	ESCITALOPRAM OXALATE	TABLET;ORAL	EQ 10MG BASE	Yes	No	2002/08/14	2002/08/14	ABBVIE	Prescription
LEXAPRO	021323	003	NDA	ESCITALOPRAM OXALATE	TABLET;ORAL	EQ 20MG BASE	Yes	Yes	2002/08/14	2002/08/14	ABBVIE	Prescription
LEXAPRO	021440	001	NDA	ESCITALOPRAM OXALATE	TABLET; ORAL	EQ 5MG BASE	No	No	2002/08/29	--	FOREST LABS	Prescription
LEXAPRO	021440	002	NDA	ESCITALOPRAM OXALATE	TABLET; ORAL	EQ 10MG BASE	No	No	2002/08/29	--	FOREST LABS	Prescription
LEXAPRO	021440	003	NDA	ESCITALOPRAM OXALATE	TABLET; ORAL	EQ 20MG BASE	No	No	2002/08/29	--	FOREST LABS	Prescription
LEXAPRO	021365	001	NDA	ESCITALOPRAM OXALATE	SOLUTION;ORAL	EQ 5MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	2002/11/27	2002/11/27	ABBVIE	Discontinued